By Justin Yamashita, MSc. Benchtop, site, CRO: three levels of basic and clinical research, explained without spin.

The deeper dive: trial methodology, mechanisms, and the science behind the story.

The Informed is Root to Rx's deep-dive science track, for when you want to check the work yourself instead of taking the plain-language version on faith. The Plain Talk newsletter covers the same topic in plain language, subscribe at RootToRx.com. This issue's Root Room, The Trial Site Exam Room.

Issue 017 traced a peptide with no label at all. This issue follows the opposite problem: a real, monitored option that plenty of people believe doesn't exist, or can't be found.

ClinicalTrials.gov is run by the U.S. National Library of Medicine. On June 25, 2024, the modernized site fully replaced the old one, with homepage search, filters, a card-view results page, and a tabbed study record [1]. It lists interventional and observational studies, recruiting and completed, worldwide.

The registry itself is younger than most people assume relative to modern medicine. The National Library of Medicine launched it in 2000, but comprehensive registration wasn't required by law until Section 801 of the FDA Amendments Act of 2007, which required most trials of drugs, biologics, and devices to register within 21 days of enrolling their first patient, with civil monetary penalties for sponsors who don't [2]. A further Final Rule took effect January 18, 2017, with compliance required from April 18, 2017, tightening what has to be reported and when [3]. For a long stretch of modern medical history, "I can't find a list of trials" wasn't paranoid. There wasn't a complete, mandatory one to find. There is now, and it's required by law.

Status tells you whether it's recruiting. Eligibility lists the inclusion and exclusion criteria. Phase tells you the stage. Contacts and Locations gives you a real person and the nearest site. Results, when posted, link the outcomes.

Prospective registration, entering a trial into the registry before it starts enrolling, closes a specific loophole: a sponsor running a trial that goes badly can otherwise decline to publish it, and the negative result quietly disappears. The International Committee of Medical Journal Editors has required prospective registration as a condition of publication in its member and follower journals since it announced the policy in September 2004, effective for trials beginning enrollment on or after July 1, 2005, and specifically before the first participant signs informed consent [4]. An ethics committee or IRB's approval to run a study does not satisfy this requirement on its own. The registry isn't just a search tool for patients. It's an accountability record for the entire field.

The WHO International Clinical Trials Registry Platform (trialsearch.who.int) meta-searches primary registries across the US, EU, UK, Japan, China, India, and more, so a patient outside the US, or looking abroad, can search many registries in one place [5]. We built a plain-language starting point for this: our Clinical Trial Registries guide links out to ClinicalTrials.gov, the WHO ICTRP, and 19 country-specific registries across Europe, Asia, Africa, and the Americas, no signup required.

The registry solved the "I can't find one" problem nearly two decades ago. The myth didn't go anywhere, because a myth doesn't need to be true to be useful to someone. Marla's entire pitch, like Cherry the Picker's and Influencer Ivy's before her, depends on you not checking. The fix here isn't complicated or expensive. It's one website, free, required by federal law since 2007. The gap was never access. It's that almost nobody tells you the list is there.

This issue concerns registry law and infrastructure, not a clinical efficacy claim, so the tiers below track source authority rather than trial evidence quality:

Tier 1: Federal statute and regulation: FDA Amendments Act of 2007, Section 801; 42 CFR Part 11 Final Rule [2][3].

Tier 2: International editorial policy: ICMJE prospective registration requirement [4].

Tier 3: Government agency operational record: NLM modernization announcement and WHO ICTRP program description [1][5].

Tier 4: Individual case, self-reported: N/A this issue.

If you work in clinical research: this is the plain-language version of a compliance requirement you already live inside every time you register a protocol.

If you are a patient or advocate: the registry is free, public, and searchable by anyone, no referral required.

"I couldn't find one" almost always means "I didn't know where to look," not "none exist."

Get the deck of questions: A Skeptic’s Toolkit — 10 Questions for Any Claim

Am I seeing the full picture? A single doctor's own patient list is a fraction of what's actually recruiting nationally and globally.

Who funded this, and do they have a stake in the answer? The person selling you an alternative benefits directly when you don't check the registry yourself.

Does the evidence match the use? A trial's eligibility criteria are specific. Reading "Eligibility" before assuming you don't qualify is the whole toolkit in one click.

Has this been replicated? The registry doesn't grade trials for you. It tells you what's being tested; you still weigh phase, sample size, and status yourself.

If this was worth your time, the best thanks is a referral. Series 1 cards are the reward.

Try it yourself: see if you’d have caught this week's Black Box Warning costume on your own.

1)       The Skeptic Type quiz sorts you into your pattern in about two minutes: openlabelmedia.com/skeptic-type.

2)       Got Skepticism? runs any claim through the same one-question move Sam just used.

3)     Stay in the Room shows you how to disagree without a fight so that you can talk to people about these difficult topics.

The quiz and both games play in your browser at openlabelmedia.com, and I would love to see your results on social media!

[1] ClinicalTrials.gov Modernization, National Library of Medicine (nlm.nih.gov/news/Modernized_ClinicalTrials.html), effective June 25, 2024.

[2] FDA Amendments Act of 2007, Public Law 110-85, Title VIII, Section 801. [VERIFY exact section citation before print.]

[3] HHS/NIH Final Rule for Clinical Trials Registration and Results Information Submission, 42 CFR Part 11, effective January 18, 2017, compliance required from April 18, 2017.

[4] ICMJE, "Clinical Trials Registration" (icmje.org/about-icmje/faqs/clinical-trials-registration/).

[5] WHO International Clinical Trials Registry Platform (trialsearch.who.int).

Instagram: instagram.com/roottorx | Facebook Lab: facebook.com/groups/theroottorxlab | TikTok: tiktok.com/@root.to.rx | YouTube: youtube.com/@roottorx | Threads: threads.com/@roottorx | Subscribe: RootToRx.com

You are receiving this because you subscribed at roottorx.com.

Disclosure: Root to Rx is published independently by Open Label Media LLC. Views expressed are personal views of Justin Yamashita and do not represent his employer or any affiliated organization. No employer resources or proprietary information are used. Every claim is sourced from publicly available materials.

Root to Rx | 228 Park Ave S, #29976, New York, New York 10003, United States